Do Low High Density Lipoprotein (HDL) Levels Predict Treatment Outcome in Patients With Chronic Hepatitis C Viral Infection?

NCT01159613 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2010-07-09

No results posted yet for this study

Summary

The working hypothesis is that the low HDL serum level predict favorable response to anti viral treatment in chronic HCV (genotype 1) viral infection. This might be used to improve the rate of sustained virologic response.

Conditions

  • Chronic Hepatitis C Viral Infection

Interventions

OTHER

Responders

Responders

OTHER

Non Responders

Non Responders

Sponsors & Collaborators

  • Hillel Yafe MC Hadera

    collaborator UNKNOWN
  • Ziv Hospital

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2008-10-31
Completion
2009-01-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01159613 on ClinicalTrials.gov